SIRT3 and B-cell chronic lymphocytic leukemia: Indeed, inhibition of endogenous ROS in CLL cells reduced SIRT3 expression (Fig. 1E) while, in vitro treatment of leukemic B-cells with exogenous H2O2, which generates ROS30 upregulated SIRT3 (Fig. 1F).